雄激素和肽生长因子对人良性前列腺增生中前列腺生长的双重调控 - Suppr | 超能文献

Dual control by androgens and peptide growth factors of prostatic growth in human benign prostatic hyperplasia.

作者信息

Serio M, Fiorelli G

机构信息

Endocrinology Unit, University of Florence, Italy.

出版信息

Mol Cell Endocrinol. 1991 Jun;78(1-2):C77-81. doi: 10.1016/0303-7207(91)90174-q.

DOI:10.1016/0303-7207(91)90174-q

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Dual control by androgens and peptide growth factors of prostatic growth in human benign prostatic hyperplasia.雄激素和肽生长因子对人良性前列腺增生中前列腺生长的双重调控

Mol Cell Endocrinol. 1991 Jun;78(1-2):C77-81. doi: 10.1016/0303-7207(91)90174-q.

2

Chemoprevention strategies for prostate cancer: the role of 5 alpha-reductase inhibitors.前列腺癌的化学预防策略：5α-还原酶抑制剂的作用

J Cell Biochem Suppl. 1992;16H:113-7. doi: 10.1002/jcb.240501226.

3

Finasteride for benign prostatic hyperplasia.非那雄胺用于治疗良性前列腺增生。

Am Fam Physician. 1992 Nov;46(5):1511-4.

4

The clinical development of a 5 alpha-reductase inhibitor, finasteride.5α-还原酶抑制剂非那雄胺的临床研发。

J Steroid Biochem Mol Biol. 1990 Nov 20;37(3):375-8. doi: 10.1016/0960-0760(90)90487-6.

5

Finasteride for benign prostatic hyperplasia.

N Engl J Med. 1993 Feb 11;328(6):443.

6

Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.5α-还原酶抑制剂非那雄胺对前列腺组织雄激素及前列腺特异性抗原的影响。

J Clin Endocrinol Metab. 1990 Dec;71(6):1552-5. doi: 10.1210/jcem-71-6-1552.

7

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.非那雄胺对良性前列腺增生男性的影响。非那雄胺研究组。

N Engl J Med. 1992 Oct 22;327(17):1185-91. doi: 10.1056/NEJM199210223271701.

8

Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.

J Clin Endocrinol Metab. 1992 Mar;74(3):505-8. doi: 10.1210/jcem.74.3.1371291.

9

The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia.非那雄胺对良性前列腺增生男性前列腺外周带和尿道周围带体积的影响。

Prostate. 1993;22(1):39-42. doi: 10.1002/pros.2990220106.

10

Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia.非那雄胺治疗良性前列腺增生的斯堪的纳维亚临床研究。

Eur Urol. 1992;22(4):271-7. doi: 10.1159/000474771.

引用本文的文献

1

Pharmacokinetics and pharmacodynamics of TF-505, a novel nonsteroidal 5alpha-reductase inhibitor, in normal subjects treated with single or multiple doses.新型非甾体5α-还原酶抑制剂TF-505在单剂量或多剂量治疗的正常受试者中的药代动力学和药效学

Br J Clin Pharmacol. 2002 Sep;54(3):283-94. doi: 10.1046/j.1365-2125.2002.01656.x.

2

Clinical application of 5alpha-reductase inhibitors.5α-还原酶抑制剂的临床应用

J Endocrinol Invest. 2001 Mar;24(3):199-203. doi: 10.1007/BF03343844.